Esophagogastric Junction Adenocarcinoma Stage IV
1 clinical trials · Condition
◉ Watch Esophagogastric Junction Adenocarcinoma Stage IV
| Record | Firm | Date |
|---|---|---|
| FOLFOX6 Versus mFOLFIRINOX as First Line Chemotherapy in Metastatic Gastric Cancer or Esophagogastric Junction Adenocarcinoma (Type II-III) (NCT04442984) | Blokhin's Russian Cancer Research Center | 2019-11-03 |
Track Esophagogastric Junction Adenocarcinoma Stage IV automatically
Every clearance here is in the API, with alerts when new ones post.